Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Atorvastatin can improve blood vessel stiffness
and blood vessel function in children 10-18 years old with Type 1 and Type 2 diabetes.
Subjects will receive atorvastatin 20mg or placebo daily for 3 months and will then switch
therapies for the next 3 months.
Hypothesis: Atorvastatin will improve blood vessel function by decreasing arterial stiffness
and improving blood flow.